Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy
Martin S. Maron, Masliza Mahmod, Azlan Helmy Abd Samat, Lubna Choudhury, Daniele Massera, Dermot Phelan, Sharon Cresci, Matthew W. Martinez, Ahmad Masri, Theodore P. Abraham, Eric Adler, Omar Wever‐Pinzon, Sherif F. Nagueh, Gregory D. Lewis, Paul Chamberlin, Jai Chand Patel, Arash Yavari, Hakim‐Moulay Dehbi, Rizwan Sarwar, Betty Raman, Ladislav Valkovič, Stefan Neubauer, James E. Udelson, Hugh Watkins
Topics & Concepts
MedicineTolerabilityPlaceboInternal medicineClinical endpointEjection fractionHypertrophic cardiomyopathyAdverse effectCardiologyHeart failureRandomized controlled trialPathologyAlternative medicineCardiomyopathy and Myosin StudiesCardiovascular Function and Risk FactorsCardiovascular Effects of Exercise